Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives
Abstract Background and purpose: Liver fibrosis, a progressive liver disease arising from viral or metabolic causes, poses a major global…
non-alcoholic fatty liver disease
The Endocannabinoid System: Implications in Gastrointestinal Physiology and Pathology
Abstract The endocannabinoid system (ECS), composed of receptors, endocannabinoids, and enzymes that regulate biosynthesis and degradation, plays a fundamental role…
Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor
Abstract Non-Alcoholic Steatohepatitis (NASH) is the progressive form of Non-Alcoholic Fatty Liver Disease (NAFLD). NASH is distinguished by severe hepatic…
Cannabidiol markedly alleviates skin and liver fibrosis
Abstract Cannabidiol (CBD) has been suggested as a potential therapy for inflammatory and fibrotic diseases. Cannabidiol was demonstrated to reduce…